All patients were pretreated with 600 mg of clopidogrel and then randomly assigned to receive intravenous abciximab or a placebo during the procedure.
所有的病人都预先给与600mg的氯吡格雷，然后随机指派接受静脉阿西单抗或者过程中应用安慰剂。
Objectives: This prospective randomized trial evaluates the impact of early abciximab administration on angiographic and left ventricular function parameters.
目的：本前瞻性、随机试验旨在评价早期使用阿昔单抗对血管造影及左室功能参数的影响。
However, a large proportion of patients in the community are treated with eptifibatide, an agent that shares some but not all pharmacological properties with abciximab.
然而，却有相当比例的患者的治疗使用了替非罗班——具有阿昔单抗的部分药理学特性。
Background: Pooled data from randomized controlled trials suggest that the use of abciximab may be associated with a survival advantage in patients undergoing primary PCI for acute STEMI.
背景——来自随机对照试验的汇萃数据表明，因急性ST段抬高型心肌梗塞行直接PC I术后的患者，使用阿昔单抗可以提高生存率。
Background: Pooled data from randomized controlled trials suggest that the use of abciximab may be associated with a survival advantage in patients undergoing primary PCI for acute STEMI.
背景——来自随机对照试验的汇萃数据表明，因急性ST段抬高型心肌梗塞行直接PC I术后的患者，使用阿昔单抗可以提高生存率。
应用推荐